Evelyn Partners, the leading integrated wealth management and professional services group, has bolstered its Cambridge office with the appointment of Mark Prince as an Audit Partner and Suzy Hawkey as Private Client Director.
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe.
Chris Dunn writes..It’s use it or lose it time! But don't just spend your end-of-year budget, invest it for maximum return. And there's no better return than investing in executive coaching or business mentoring.
ALUMNI of University of Cambridge’s hugely successful entrepreneurship and intrapreneurship programme, impulse continue to shine as the application window for the new 2024 intake opens.
It is difficult to imagine someone who hasn’t called on antibiotics to help them through an infection or protect them during a surgery. Thanks to developments over the last 150 years, once life-threatening bacterial encounters have been relegated to minor inconveniences. Or have they?
Chris Dunn writes...Leading change is one of the most challenging aspects of leadership. This is not only because the pace of change is accelerating but also because so much seems to be changing all at the same time. So, where do leaders and senior managers get the right support to help them make more of the right calls about change management?
100 experts from Graphcore, Arm, Google and Stripe come together to support the next generation of Cambridge startups
Founders at the University of Cambridge opens applications to its first pre-seed accelerator.
By Mohamed Awad, SVP and GM of the Infrastructure Business, Arm.
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success, along with R&D and commercial.
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
There is growing interest in the innovation process in the biopharmaceutical industry, with particular public scrutiny around the composition of research and development (R&D) spending and the role of intellectual property.
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future competito
Cambridge, UK: Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has recently published a letter to its shareholders containing the company’s results for its fiscal second quarter and three months ended September 30, 2023.
Not all executive coaches and business mentors are equal. The differences matter.
Team Coaching Boutique writes..We have now completed the successful employee engagement pilot using our AI based development platform and the feedback was strong. A few snippet's are given below. A full testimonial is available on request or from the website.
Firms are wrestling with how to convince staff to use artificial intelligence (AI) and other new technologies. A study led at Cambridge Judge, focusing on social comparisons among employees, cautions against a false dichotomy between full and no adoption.
Based on existing evidence on the delay, lack of recognition, and burden of pain conditions commonly afflicting women (specifically endometriosis, PCOS, fibromyalgia, IBS or migraines), CRA sought to understand how being diagnosed with these conditions impacts women’s mental health and healthcare
The second of a two-part article, CRA’s Life Sciences Practice team, along with experts at The Janssen Pharmaceutical Companies of Johnson & Johnson, recently conducted a landscape review of how complex pharmaceutical innovation happens in practice, leveraging three therapy area case studies:
With the growing popularity of digital product design and UX design the word prototypes is becoming synonymous with digital mock-ups and testing apps.
Cambridge, UK - The Cambridge Crystallographic Data Centre (CCDC) announces a three-year extension with partners Orgmento, a software engineering and data sciences company based in Accra, Ghana.
Cambridge - EY has achieved a second year of double-digit revenue growth, with UK revenues up 16% and fee income increasing to a record £3.76bn from £3.23bn the previous year. This market leading performance has been underpinned by long term investments in people, audit quality and technology. Distributable profits before tax remained broadly flat at £659m.
National Mentoring Day has arrived. Mentoring matters and it's time to shine a spotlight on mentors and mentees and the proven benefits of this unique relationship.
This article is originally published in PharmaPhorum.